PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Clinical trials for PRIMARY IMMUNODEFICIENCY DISEASES (PID) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IMMUNODEFICIENCY DISEASES (PID) trials appear
Sign up with your email to follow new studies for PRIMARY IMMUNODEFICIENCY DISEASES (PID), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test gene therapy approach for rare immune diseases in lab
Knowledge-focused Recruiting nowThis study aims to understand how JAK inhibitor drugs affect immune cells in people with rare genetic immune disorders. Researchers will examine blood samples from 20 adult participants to see how these drugs change cell behavior and test whether a gene therapy approach might wor…
Matched conditions: PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Phase: NA • Sponsor: prof. dr. Rik Schrijvers • Aim: Knowledge-focused
Last updated Apr 04, 2026 03:21 UTC
-
Drug safety under review: study scans patient records for rare reactions
Knowledge-focused Recruiting nowThis study aims to check the safety of an existing treatment called Cuvitru in people with primary immunodeficiency (PID). Researchers will look back at the medical records of about 100 patients in Japan to see if they experienced specific, serious side effects. The goal is to ga…
Matched conditions: PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:21 UTC